This list is an analysis based on recent market events. It's not an investment recommendation.
About
Pell Bio-Med Technology Co., Ltd., established in 2017 and headquartered in Taipei, Taiwan, operates as a biomedical firm specializing in advanced cell culture technologies and methods for therapeutic applications. The company's commercial portfolio encompasses good tissue practice (GTP) laboratory infrastructure, adipose-derived stem cells (ADSC) utilized in regenerative medicine, and both CIK and DC-CIK therapies aimed at combating various cancers. Beyond its existing products, Pell Bio-Med is actively engaged in developing novel pharmaceuticals for diverse cancer types, pioneering cell immunotherapy strategies, and advancing stem cell regenerative therapy techniques. Its research and development efforts extend to cutting-edge areas such as chimeric antigen receptor T cell (CAR-T), CAR-NK, CAR-?dT, and genetically modified ADSC technologies. The company is also progressing product development specifically targeting indications like B-cell non-Hodgkin lymphoma (B-NHL), ovarian cancer, multiple myeloma, and thyroid cancer.
What is PELL Bio-Med Technology stock price today?▼
The current price of 6949.TW is TWD53.00 TWD — it has decreased by -9.86% in the past 24 hours. Watch PELL Bio-Med Technology stock price performance more closely on the chart.
What is PELL Bio-Med Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan Stock Exchange exchange PELL Bio-Med Technology stocks are traded under the ticker 6949.TW.
Is PELL Bio-Med Technology stock price growing?▼
6949.TW stock has fallen by -28.86% compared to the previous week, the month change is a -94.8% fall, over the last year PELL Bio-Med Technology has showed a -87.97% decrease.
What is PELL Bio-Med Technology market cap?▼
Today PELL Bio-Med Technology has the market capitalization of 3.44B
What is PELL Bio-Med Technology revenue for the last year?▼
PELL Bio-Med Technology revenue for the last year amounts to 31.42M TWD.
What is PELL Bio-Med Technology net income for the last year?▼
6949.TW net income for the last year is -429.07M TWD.
How many employees does PELL Bio-Med Technology have?▼
As of September 13, 2026, the company has 94 employees.
In which sector is PELL Bio-Med Technology located?▼
PELL Bio-Med Technology operates in the Health & Wellness sector.
When did PELL Bio-Med Technology complete a stock split?▼
PELL Bio-Med Technology has not had any recent stock splits.
Where is PELL Bio-Med Technology headquartered?▼
PELL Bio-Med Technology is headquartered in Taipei, Taiwan.